Analyst Round-Up Intel (INTC): 25 Analysts Play Catch-Up (Raise Price Targets)
As expected, almost every firm on the Street with a research branch has issued a report on Intel (Nasdaq: INTC) today following its Q3 earnings report. While analysts seem to be staying pat on their investment ratings, most are adjusting their estimates and price targets accordingly.
Below is a summary of the analyst action on shares of Intel:
- Goldman Sachs - maintains Neutral, price target raised from $16 to $17
- Morgan Stanley - maintains Overweight, price target raised from $24 to $25
- Deutsche Bank - maintains Buy, price target raised from $24 to $25
- BofA Merrill Lynch - maintains Buy, price target raised from $25 to $27
- Barclays - maintains Equalweight, price target raised from $22 to $24
- Citi - maintains Buy, price target raised from $25 to $26
- UBS - maintains Buy, price target raised from $24 to $27
- Credit Suisse - maintains Outperform, price target raised from $24 to $27
- Piper Jaffray - maintains Overweight, price target raised from $21 to $26
- Oppenheimer - maintains Outperform, sets price target of $28
- FBR Capital - maintains Market Perform, price target raised from $23 to $27
- Wedbush - maintains Outperform, price target raised from $25 to $26
- Bernstein - maintains Market Perform, price target raised from $19.50 to $21.50
- Needham - maintains Buy, price target raised from $24 to $28
- Jefferies - maintains Underperform, price target raised from $14 to $15
- Roth Capital - maintains Buy, price target raised from $25 to Street high $33
- Auriga - maintains Sell, price target raised from $16 to $17
- Calyon - maintains Underperform, price target raised from $20 to $23
- Broadpoint.AmTech - maintains Buy, price target raised from $25 to $29
- JMP Securities - maintains Outperform, price target raised from $24 to $28
- Davenport - maintains Buy, raises price target from $27 to $29
- Miller Tabak - maintains Buy, price target raised from $22 to $25
- Canaccord Adams - maintains Buy, price target raised from $20 to $25
- FTN Equity - maintains Buy, price target raised from $23 to $25
- GC Research - maintains Neutral, price target raised from $21 to $24
Now the real question to ask... is it a good or bad thing that all these analysts are jumping on the bandwagon?
Create E-mail AlertRelated Categories
Analyst CommentsInsiders' Blog
Trader Talk
Stocks Mentioned
Related Entities
- Credit Suisse
- Piper Jaffray
- Deutsche Bank
- UBS
- Citi
- Morgan Stanley
- Jefferies & Co
- Merrill Lynch
- Davenport
- Canaccord Adams
- Calyon Securities
- Needham & Company
- Bank of America
- Roth Capital
- American Technology Research
- JMP Securities
- Barclays
- EIM Group
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
